嚢胞性線維症(CF症)治療薬の世界市場...市場調査レポートについてご紹介

【英文タイトル】Global Cystic Fibrosis Market 2015-2019

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

01. Executive Summary

02.List of Abbreviations

03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings

04.Product Profiles
04.1.1 Zenpep/ Ultresa/ Ultrase/ Ultrase MT
04.1.2 Colomycin/ Colobreathe
04.1.3 Pulmozyme
04.1.4 Cayston
04.1.5 TOBI/ TOBI Podhaler
04.1.6 Kalydeco

05.Market Research Methodology
05.1 Market Research Process
05.2 Research Methodology

06.Introduction

07.Disease Overview
07.1 Understanding the Disease
07.2 Pathophysiology
07.3 Epidemiology
07.3.1 Global
07.3.2 North America
07.3.3 Europe
07.3.4 Africas
07.3.5 Latin America
07.3.6 Middle East
07.3.7 Asia and Oceania
07.4 Diagnosis
07.4.1 Newborn Screening
07.4.2 Carrier Testing
07.4.3 Antenatal Testing
07.4.4 Other Tests
07.5 Manifestations of Cystic Fibrosis
07.6 Economic Burden

08.Market Landscape
08.1 Market Overview
08.2 Market Size and Forecast
08.3 Five Forces Analysis

09.Market Segmentation by Molecule Type
09.1 Biologics
09.1.1 Enzymes
09.2 Small Molecules
09.2.1 CFTR Modulator
09.2.2 Antibiotics

10.Market Segmentation by Route of Administration
10.1 Oral
10.2 Parenteral
10.3 Topical

11.Market Segmentation by Dosage Form
11.1 Solid
11.2 Liquid

12.Geographical Segmentation
12.1 Cystic Fibrosis Market in the Americas
12.1.1 Cystic Fibrosis Market in the US
12.1.2 Cystic Fibrosis Market in the Latin America
12.1.3 Cystic Fibrosis Market in the Canada
12.2 Cystic Fibrosis Market in the EMEA Region
12.2.1 Market Size and Forecast
12.3 Cystic Fibrosis Market in the APAC Region
12.3.1 Market Size and Forecast

13.Key Leading Countries
13.1 US
13.2 UK
13.3 France
13.4 Canada
13.5 Italy

14.Buying Criteria

15.Market Growth Drivers

16.Drivers and their Impact

17.Market Challenges

18.Impact of Drivers and Challenges

19.Market Trends

20.Trends and their Impact

21.Vendor Landscape
21.1 Competitive Scenario
21.1.1 Key News
21.1.2 Mergers and Acquisitions
21.2 Market Share Analysis 2014
21.2.1 F. Hoffmann-La Roche
21.2.2 Novartis
21.2.3 Vertex Pharmaceuticals
21.2.4 Actavis
21.2.5 Gilead Sciences
21.3 Other and Future Prominent Vendors

22.Key Vendor Analysis
22.1 Actavis
22.1.1 Key Facts
22.1.2 Business Description
22.1.3 Business Segmentation
21.1.4 Revenue by Business Segmentation
22.1.5 Revenue Comparison 2013 and 2014
22.1.6 Sales by Geography
22.1.7 Business Strategy
22.1.8 Key Developments
22.1.9 SWOT Analysis
22.2 F. Hoffmann-La Roche
22.2.1 Key Facts
22.2.2 Business Description
22.2.3 Business Segmentation
22.2.4 Revenue by Business Segmentation
22.2.5 Revenue Comparison 2013 and 2014
22.2.6 Sales by Geography
22.2.7 Business Strategy
22.2.8 Key Developments
22.1.9 SWOT Analysis
22.3 Gilead Sciences
22.3.1 Key Facts
22.3.2 Business Description
22.3.3 Business Segmentation
22.3.4 Revenue by Business Segmentation
22.3.5 Revenue Comparison 2013 and 2014
22.3.6 Sales by Geography
22.3.7 Business Strategy
22.3.8 Key Developments
22.3.9 SWOT Analysis
22.4 Novartis
22.4.1 Key Facts
22.4.2 Business Description
21.4.3 Business Segmentation
22.4.4 Revenue by Business Segmentation
22.4.5 Revenue Comparison 2013 and 2014
22.4.6 Sales by Geography
22.4.7 Business Strategy
22.4.8 Key Developments
22.4.9 SWOT Analysis
22.5 Vertex Pharmaceuticals
22.5.1 Key Facts
22.5.2 Business Description
22.5.3 Business Segmentation
22.5.4 Revenue by Business Segmentation
22.5.5 Revenue Comparison 2013 and 2014
22.5.6 Sales by Geography
22.5.7 Business Strategy
22.5.8 Key Developments
22.5.9 SWOT Analysis

23.Other Reports in this Series

[List of Exhibits]
Exhibit 1: Market Research Methodology
Exhibit 2: Snapshot Of Cystic Fibrosis Disease
Exhibit 3: Defects Caused by CFTR Mutation
Exhibit 4: Epidemiology of Cystic Fibrosis in the World 2012
Exhibit 5: Prevalence of Cystic Fibrosis by Country 2014
Exhibit 6: Prevalence Number of Cystic Fibrosis by Country 2014
Exhibit 7: Snapshot of US Prevalence of Cystic Fibrosis 2014
Exhibit 8: Forecast of Cystic Fibrosis Prevalence in US 2014-2019
Exhibit 9: Epidemiology Based on the Education Level in US, 2011
Exhibit 10: Epidemiology based on the Marital Status in US, 2011
Exhibit 11: Epidemiology based on the Employment Status in US, 2011
Exhibit 12: Forecast of Cystic Fibrosis Prevalence in Canada 2014-2019
Exhibit 13: Forecast of Cystic Fibrosis Prevalence in the UK 2014-2019
Exhibit 14: Age Distribution at Death for Cystic Fibrosis Patients in UK, 2013
Exhibit 15: Age Distribution by Gender for Cystic Fibrosis Patients in the UK, 2013
Exhibit 16: Age Distribution by Sex for Cystic Fibrosis Patients in the UK, 2013
Exhibit 17: Diagnosis of Cystic Fibrosis
Exhibit 18: The Manifestations of Cystic Fibrosis
Exhibit 19: Snapshot of the Economic Burden of Cystic Fibrosis
Exhibit 20: Snapshot of Global Cystic Fibrosis Market 2014
Exhibit 21: Global Cystic Fibrosis Market 2014-2019 (US$ million)
Exhibit 22: Global Cystic Fibrosis Market Segmentation By Class of Drugs
Exhibit 23: Global Cystic Fibrosis Drugs Market Segmentation by Molecule Type 2014
Exhibit 24: Global Cystic Fibrosis Market Segmentation By Route Of Administration
Exhibit 25: Global Cystic Fibrosis Drugs Market Segmentation by Route of Administration 2014
Exhibit 26: Global Cystic Fibrosis Market Segmentation by Dosage Form
Exhibit 27: Global Cystic Fibrosis Drugs Market Segmentation by Dosage Form 2014
Exhibit 28: Global Cystic Fibrosis Market by Geographical Segmentation 2014 and 2019
Exhibit 29: Global Cystic Fibrosis Market Revenue by Geographical Segmentation 2014-2019 (US$ million)
Exhibit 30: Global Cystic Fibrosis Market Growth Rate by Region 2014-2019
Exhibit 31: Revenue (US$ million) and CAGR of Global Cystic Fibrosis Market by Geographical Segments 2014 and 2019
Exhibit 32: Global Cystic Fibrosis Market by Country/Region 2014
Exhibit 33: Global Cystic Fibrosis Market by Country/Region 2014 (US$ million)
Exhibit 34: Cystic Fibrosis Market in the Americas 2014-2019 (US$ million)
Exhibit 35: Cystic Fibrosis Market Revenue in the Americas 2014-2019
Exhibit 36: Cystic Fibrosis Market Growth Rate in the Americas 2014-2019
Exhibit 37: Cystic Fibrosis Market in the Americas by Region 2014 and 2019
Exhibit 38: Revenue (US$ million) and CAGR of Cystic Fibrosis Market in the Americas by Regions 2014 and 2019
Exhibit 39: Cystic Fibrosis Market in the US 2014-2019 (US$ million)
Exhibit 40: Cystic Fibrosis Market in the Latin America 2014-2019 (US$ million)
Exhibit 41: Cystic Fibrosis Market in Canada 2014-2019 (US$ million)
Exhibit 42: Cystic Fibrosis Market in EMEA 2014-2019 (US$ million)
Exhibit 43: Cystic Fibrosis Market in EMEA by Country/Region 2014
Exhibit 44: Cystic Fibrosis Market in APAC 2014-2019 (US$ million)
Exhibit 45: Buying Criteria of Global Cystic Fibrosis Market
Exhibit 46: Global Cystic Fibrosis Market Share Analysis 2014
Exhibit 47: Global Sales Comparison of Pulmozyme 2013 vs 2012 (US$ Million)
Exhibit 48: Quarterly Sales Comparison of Pulmozyme in the US 1994-2008 (US$ Million)
Exhibit 49: Quarterly Sales Comparison of Pulmozyme Sales to Collaborators 1997-2008 (US$ Million)
Exhibit 50: Quarterly Sales Comparison of Pulmozyme Total Sales 1994-2008 (US$ Million)
Exhibit 51: Total Global Sales Comparison of Pulmozyme 1994-2008 (US$ Million)
Exhibit 52: TOBI Podhaler
Exhibit 53: YoY Sales Comparison of TOBI and TOBI Podhaler 2006-2013 (US$ Million)
Exhibit 54: YoY Sales Comparison of Kalydeco 2012-2013 (US$ Million)
Exhibit 55: Actavis: Business Segmentation 2014
Exhibit 56: Actavis: Business Segmentation by Revenue 2013 and 2014 (US$ million)
Exhibit 57: Actavis : Sales by Geography (in US$ million)
Exhibit 67: F. Hoffmann-La Roche Ltd.: Business Segmentation by Revenue 2013 and 2014
Exhibit 68: F. Hoffmann-La Roche Ltd.: Sales by Geography 2014 (Pharmaceuticals Division)
Exhibit 69: F. Hoffmann-La Roche Ltd.: Sales by Geography 2014 (Diagnostics Division)
Exhibit 63: Gilead Sciences: Business Segmentation by Revenue 2014
Exhibit 64: Gilead Sciences: Business Segmentation by Revenue 2013 and 2014 (US$ million)
Exhibit 65: Gilead Sciences: Sales by Geography 2014
Exhibit 18: Novartis AG: Business Segmentation
Exhibit 19: Novartis AG: Revenue by Business Segmentation 2014
Exhibit 20: Novartis AG: Revenue by Business Segmentation 2013 and 2014 (US$ million)
Exhibit 21: Novartis AG: Revenue by Geographical Segmentation 2014
Exhibit 63: Vertex Pharmaceuticals: Business Segmentation by Revenue 2014
Exhibit 64: Vertex Pharmaceuticals: Business Segmentation by Revenue 2013 and 2014 (US$ million)
Exhibit 65: Vertex Pharmaceuticals: Sales by Geography 2014


【レポート販売概要】

■ タイトル:嚢胞性線維症(CF症)治療薬の世界市場
■ 英文:Global Cystic Fibrosis Market 2015-2019
■ 発行日:2014年12月17日
■ 調査会社:Technavio
■ 商品コード:IRTNTR4842
■ 調査対象地域:グローバル
  • 都市用水・下水処理用化学薬品のヨーロッパ市場2017-2021
    ABSTRACTAbout Municipal Water and Wastewater Treatment Chemicals Municipal water treatment (purification) is the process of removing undesirable chemicals, materials, and biological contaminants from raw water. Municipal wastewater treatment is the process of removing all kinds of contaminants from wastewater and household sewage, both runoff (effluents) and domestic. The objective of these proces …
  • フランスの気道装置・麻酔装置市場
    France Airway and Anesthesia Devices Market Outlook to 2021 Summary GlobalData’s new report, "France Airway and Anesthesia Devices Market Outlook to 2021", provides key market data on the France Airway and Anesthesia market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - Anesthesia Circuits, Anesthesia Masks, …
  • アメリカのスマートホーム市場(製品別、サービス別、地域別分析と予測)
    ‘Smart home’ denotes a residence furnished with advanced computational and operational network that automatically operates and responds to the requirements of its residents. This has a major impact on the occupants’ luxury and convenience. These smart homes also serve the purpose of enhancing security measures, and offering lively and timely entertainment purposes, with a clear inclination towards …
  • 希突起膠腫(Oligodendroglioma):治療薬開発パイプライン動向(2015年上半期版)
    Oligodendroglioma - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Oligodendroglioma - Pipeline Review, H1 2015’, provides an overview of the Oligodendroglioma’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Oligodendroglioma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism …
  • メタリック顔料の世界市場2017-2021:アルミニウム顔料、銅顔料、亜鉛顔料、ステンレス鋼顔料
    About Metallic Pigments Metallic pigments are inorganic pigments with metallic characteristics. These pigments are flake-shaped metallic particles that are available as pastes, powders, pellets, suspensions, or color concentrates. Metallic pigments usually consist of aluminum, gold, zinc, bronze, stainless steel, and nickel. These pigments are used in anticorrosion, heat resistant, reflective, and …
  • 手術用顕微鏡の世界市場
    Developing markets such as the Middle East, Brazil, Argentina, Mexico, China, and India are lucrative markets for surgical microscopes, owing to favorable government incentives. The report segments the surgical microscopes market is segmented on the basis of application, end user, and region. On the basis of applications, the surgical microscopes applications market is categorized into neuro & spi …
  • コールドカットの世界市場2017-2021
    About Cold Cuts The global processed meat market is expected to grow at a steady pace during the forecast period. With globalization and urbanization, consumer lifestyles are becoming busier and the number of dual-income households are rising. Ready-to-eat meat products that contain essential nutrients and save the cooking time of the consumers are being largely preferred by these household. Due t …
  • 世界の自動車用アフターマーケットショックアブソーバー市場:車両種類別、地域別
    Global Automotive Aftermarket Shock Absorbers Market: About this market Technavio’s automotive aftermarket shock absorbers market analysis considers sales from both passenger vehicles and commercial vehicle types. Our study also finds the sales of automotive aftermarket shock absorbers in APAC, Europe, MEA, North America, and South America. In 2019, the passenger vehicle segment had a significant …
  • 艦艇MRO(整備・修理・分解点検)の世界市場2016-2020
    About Naval Vessels MRO Naval vessels are differentiated from civilian ships by their design and purpose. Such ships are damage resilient and armed. Naval vessels MRO is crucial for sustaining and extending the life of a vessel. It comprises maintenance, overhauls, routine checks, inspections, repairs, and modifications carried out on a vessel and their components. MRO services assure the safety a …
  • RFIDリーダーの世界市場2016-2020
    RFID readers play a critical role in inventory management and are finding tremendous response in many big stores, supermarkets, hypermarkets, and apparel stores. This market research report by Technavio emphasizes on the involvement of RFID readers in different end-user segments like healthcare, transportation, and retail. The increasing incorporation of RFID readers in these segments is expected …
  • エンコーダーの世界市場予測(~2024年)
    “Encoders market to grow at significant rate from 2019 to 2024” The encoders market is expected to grow from USD 1.6 billion in 2019 to USD 2.4 billion by 2024—at a CAGR of 8.6%. Key factors driving the growth of the encoders market include the need for high-end automation and industry 4.0. Strategies such as product launches adopted by market players are fueling the growth of the encoders market. …
  • 頭蓋内圧(ICP)モニタリングの世界市場2016-2020
    About ICP ICP monitoring is used to measure the pressure within the skull of an individual with severe head injuries to decide the type of treatment required and to track the progression of the condition during treatment. It is a vital for individuals who are under critical care in hospitals. ICP monitoring is indicated in most comatose individuals with severe head injuries. It should be used to t …
  • 航空機用無線ルーターの世界市場予測・分析2019-2023
    Global Aircraft Wireless Routers Market: About this market Technavio’s aircraft wireless routers market analysis considers sales from both commercial and business aircraft and military aircraft. Our analysis also considers the sales of aircraft wireless routers in APAC, Europe, North America, South America, and MEA. In 2018, the commercial and business aircraft segment had a significant market sha …
  • 清掃請負サービスの世界市場2018-2022
    About Contract Cleaning Services Contract cleaning is an outsourced cleaning service that includes a mix of services that are available at a fixed cost, for a given period. These services are offered for residential, industrial, and commercial end-users. Customers do not need to experience the hassle of hiring permanent employees and can leave their daily, monthly, or weekly cleaning requirements …
  • てんかん(Epilepsy):グローバル治療薬予測と市場分析
    PharmaPoint: Epilepsy - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update Summary Epilepsy is a brain disorder characterized by spontaneously occurring and recurrent seizures. The market is heavily driven by the sales of antiepileptic drugs (AEDs) targeted at seizure reduction. The AED market is currently dominated by UCB’s Keppra and GlaxoSmithKline’s Lamictal. Although both …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。